Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide

Infection and Immunity

Volumn 78, Issue 3, 2010, Pages 1185-1192

  Nakagaki, Hidetaka ^a   Sekine, Shinichi ^a   Terao, Yutaka ^a   Toe, Masahiro ^a   Tanaka, Muneo ^a   Ito, Hiro O ^b   Kawabata, Shigetada ^a   Shizukuishi, Satoshi ^a   Fujihashi, Kohtaro ^c   Kataoka, Kosuke ^a,b,c  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; ENVELOPE PROTEIN; HEXAPEPTIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; POLYVINYLCHLORIDE; PROTEIN FOMA; TYROSYLGLUTAMINYLPROLYLVALYLPROLYLGLUTAMIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL IMMUNITY; BINDING AFFINITY; BIOFILM; CONTROLLED STUDY; FEMALE; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NUCLEATUM; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR WEIGHT; MOUSE; MOUTH INFECTION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SALIVA; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; FEMALE; FUSOBACTERIUM NUCLEATUM; GENE DELETION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KINETICS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MUCOUS MEMBRANE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SALIVARY PROTEINS AND PEPTIDES;

EID: 77349112434     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01224-09     Document Type: Article

References (44)

1. Amano, A., H. T. Sojar, J.-Y. Lee, A. Sharma, M. J. Levine, and R. J. Genco. 1994. Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect. Immun. 62:3372-3380.
2. Amano, A., K. Kataoka, P. A. Raj, R. J. Genco, and S. Shizukuishi. 1996. Binding sites of salivary statherin for Porphyromonas gingivalis recombinant fimbrillin. Infect. Immun. 64:4249-4254.
3. Amano, A., T. Nakamura, S. Kimura, I. Morisaki, I. Nakagawa, S. Kawabata, and S. Hamada. 1999. Molecular interaction of Porphyromonas gingivalis fimbriae with host proteins: kinetic analysis based on surface plasmon resonance. Infect. Immun. 67:2399-2405.
4. Bradshaw, D. J., P. D. Marsh, G. K. Watson, and C. Allison. 1998. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect. Immun. 66:4729-4732.
5. Couch, R. B. 2004., Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N. Engl. J. Med. 350:860-861.
6. Edman, P. 1949. A method for the determination of amino acid sequence in peptides. Arch. Biochem. 22:475.
7. Etchart, N., B. Baaten, S. R. Andersen, L. Hyland, S. Y. C. Wong, and S. Hou. 2006. Intranasal immunization with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge. Eur. J. Immunol. 36:1136-1144.
8. Fletcher, H. M., H. A. Schenkein, R. M. Morgan, K. A. Bailey, C. R. Berry, and F. L. Macrina. 1995. Virulence of Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect. Immun. 63:1521-1528.
9. Fujihashi, K., P. N. Boyaka, and J. R. McGhee. 2008. Host defense at mucosal surfaces, p. 287-304. In R. R. Rich, T. A. Fleisher, W. T. Shearer, et al. (ed.), Clinical immunology: principles and practice, 3rd ed. Mosby/ Elsevier, St. Louis, MO.
10. Fukuiwa, T., S. Sekine, R. Kobayashi, H. Suzuki, K. Kataoka, R. S. Gilbert, Y. Kurono, P. N. Boyaka, A. M. Kreig, J. R. McGhee, and K. Fujihashi. 2008. A recombination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine 26: 4849-4859.
11. + T cells in nasopharyngeal-associated lymphoreticular tissues. J. Immunol. 170:1754-1762.
12. Han, Y. W., W. Shi, G. T. Huang, S. Kinder Haake, N. H. Park, H. Kuramitsu, and R. J. Genco. 2000. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect. Immun. 68:3140-3146.
13. Hay, D. I. 1973. The isolation from human parotid saliva of a tyrosine-rich acidic peptide which exhibits high affinity for hydroxyapatite surfaces. Arch. Oral Biol. 18:1531-1541.
14. Hay, D. I., and E. C. Moreno. 1989. Statherin and the acidic proline-rich proteins, p. 131-150. In J. Tenovuo (ed.), Human saliva: clinical chemistry and microbiology. CRC Press, Boca Raton, FL.
15. Kataoka, K., K. Fujihashi, S. Sekine, T. Fukuiwa, R. Kobayashi, H. Suzuki, H. Nagata, K. Takatsu, S. Shizukuishi, J. R. McGhee, and K. Fujihashi. 2007. Nasal cholera toxin elicits IL-5 and IL-5 receptor α-chain expressing B-1a B cells for innate mucosal IgA antibody responses. J. Immunol. 178: 6058-6065.
16. + dendritic cells for enhanced mucosal immunity. J. Immunol. 172:3612-3619.
17. Kaufman, J., and J. M. DiRienzo. 1989. Isolation of a corncob (coaggregation) receptor polypeptide from Fusobacterium nucleatum. Infect. Immun. 57:331-337.
18. Kesavalu, L., S. Sathishkumar, V. Bakthavatchalu, C. Matthews, D. Dawson, M. Steffen, and J. L. Ebersole. 2007. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect. Immun. 75:1704-1712.
19. Kinder, S. A., and S. C. Holt. 1989. Characterization of coaggregation between Bacteroides gingivalis T22 and Fusobacterium nucleatum T18. Infect. Immun. 57:3425-3433.
20. Kinder, S. A., and S. C. Holt. 1993. Localization of the Fusobacterium nucleatum T18 adhesion activity mediating coaggregation with Porphyromonas gingivalis T22. J. Bacteriol. 175:840-850.
21. Kleivdal, H., R. Benz, and H. B. Jensen. 1995. The Fusobacterium nucleatum major outer-membrane protein (FomA) forms trimeric, water-filled channels in lipid bilayer membranes. Eur. J. Biochem. 233:310-316.
22. Kolenbrander, P. E., and J. London. 1993. Adhere today, here tomorrow: oral bacterial adherence. J. Bacteriol. 175:3247-3252.
23. Liu, H., R. W. Redline, and Y. W. Han. 2007. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J. Immunol. 179:2501-2508.
24. McGhee, J. R., and H. Kiyono. 1999. The mucosal immune system, p. 909-930. In W. E. Paul (ed.), Fundamental immunology, 4th ed. Lippincott-Raven Publishers, Philadelphia, PA.
25. Mestecky, J., R. S. Blumberg, H. Kiyono, and J. R. McGhee. 2003. The mucosal immune system, p. 965-1020. In W. E. Paul (ed.), Fundamental immunology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
26. Moldoveanu, Z., M. L. Clements, S. J. Prince, B. R. Murphy, and J. Mestecky. 1995. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 11:1006-1012.
27. Momoi, F., T. Hashizume, T. Kurita-Ochiai, Y. Yuki, H. Kiyono, and M. Yamamoto. 2008. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Infect. Immun. 76:2777-2784.
28. Niemi, D. L., and I. Johansson. 2004. Salivary statherin peptide binding epitopes of commensal and potentially infectious Actinomyces spp. delineated by a hybrid peptide construct. Infect. Immun. 72:782-787.
29. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64: 1516-1525.
30. Okamoto, S., S. Kawabata, Y. Terao, H. Fujitaka, Y. Okuno, and S. Hamada. 2004. The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection. Infect. Immun. 72:6068-6075.
31. O'Toole, G. A., and R. Kolter. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signaling pathways: a genetic analysis. Mol. Microbiol. 28:449-461.
32. Ribot, S., K. Gal, M. V. Goldblat, and H. H. Eslami. 1981. The role of anaerobe bacteria in the pathogenesis of urinary tract infections. J. Urol. 126:852-853.
33. Sekine, S., K. Kataoka, M. Tanaka, H. Nagata, T. Kawakami, K. Akaji, S. Aimoto, and S. Shizukuishi. 2004. Active domains of salivary statherin on apatitic surfaces for binding to Fusobacterium nucleatum cells. Microbiology 150:2373-2379.
34. Shah, P., D. E. Briles, J. King, Y. Hale, and E. Swiatio. 2009. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae. Exp. Biol. Med. 234:403-409.
35. Siqueira, J. F., Jr., and I. N. Rocas. 2009. The microbiota of acute abscesses. J. Dent. Res. 88:61-65.
36. Takada, H., T. Ogawa, F. Yoshimura, K. Otsuka, S. Kokeguchi, K. Kato, T. Umemoto, and S. Kotani. 1988. Immunological activities of a porin fraction isolated from Fusobacterium nucleatum ATCC 10953. Infect. Immun. 56: 855-863.
37. Terao, Y., S. Okamoto, K. Kataoka, S. Hamada, and S. Kawabata. 2005. Protective immunity against Streptococcus pyogenes challenge in mice after immunization with fibronectin-binding protein. J. Infect. Dis. 192:2081-2091.
38. Vadolas, J., J. K. Davis, P. J. Wright, and R. A. Strungnell. 1995. Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur. J. Immunol. 25:969-975.
39. Vajdy, M., M. H. Kosco-Vilbois, M. Kopf, G. Kohler, and N. Lycke. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181:41-53.
40. Winkler, J. R., S. R. John, R. H. Kramer, C. I. Hoover, and P. A. Murray. 1987. Attachment of oral bacteria to a basement-membrane-like matrix and to purified matrix proteins. Infect. Immun. 55:2721-2726.
41. Xie, H., R. J. Gibbons, and D. I. Hay. 1991. Adhesive properties of strains of Fusobacterium nucleatum of the subspecies nucleatum, vincentii and polymorphum. Oral Microbiol. Immunol. 6:257-263.
42. Xu-Amano, J., R. J. Jackson, K. Fujihashi, H. Kiyono, H. F. Staats, and J. R. McGhee. 1994. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12:903-911.
43. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, K. Fujihashi, F. W. van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. U. S. A. 94:5267-5272.
44. Yanagita, M., T. Hiroi, N. Kitagaki, S. Hamada, H. Ito, H. Shimauchi, S. Murakami, H. Okada, and H. Kiyono. 1999. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J. Immunol. 162:3559-3565.